{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T00:51:32Z","timestamp":1773276692095,"version":"3.50.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Endocrinol Invest"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1007\/bf03345311","type":"journal-article","created":{"date-parts":[[2014,3,29]],"date-time":"2014-03-29T09:58:45Z","timestamp":1396087125000},"page":"1065-1071","source":"Crossref","is-referenced-by-count":28,"title":["Thyroid, hemostasis and thrombosis"],"prefix":"10.1007","volume":"27","author":[{"given":"F.","family":"Marongiu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Cauli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Mariotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,3,18]]},"reference":[{"key":"BF03345311_CR1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/978-1-59259-352-1_7","volume-title":"Diseases of the thyroid","author":"S Mariotti","year":"2003","unstructured":"Mariotti S, Pinna G. Autoimmune thyroid disease. In: Bravermam L ed. Diseases of the thyroid. Totowa: Humana Press. 2003, 107\u201360."},{"key":"BF03345311_CR2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1055\/s-0038-1645220","volume":"63","author":"F Marongiu","year":"1990","unstructured":"Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E. What causes the increase in platelet mean volume in thyroid pathological conditions? Thromb Haemost 1990, 63: 323\u20134.","journal-title":"Thromb Haemost"},{"key":"BF03345311_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/ajh.2830270308","volume":"27","author":"HC Ford","year":"1988","unstructured":"Ford HC, Toomath RJ, Carter JM, Delahunt JW, Fagerstrom JN. Mean platelet volume is increased in hyperthyroidism. Am J Hematol 1988, 27: 190\u20133.","journal-title":"Am J Hematol"},{"key":"BF03345311_CR4","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1210\/jcem-70-2-491","volume":"70","author":"S Panzer","year":"1990","unstructured":"Panzer S, Haubenstock A, Minar E. Platelets in hyperthyroidism: studies on platelet counts, mean platelet volume, 111-indiumlabeled platelet kinetics, and platelet-associated immunoglobulins G and M. J Clin Endocrinol Metab 1990, 70: 491\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345311_CR5","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1046\/j.1365-2141.1998.00765.x","volume":"101","author":"G Stiegler","year":"1998","unstructured":"Stiegler G, Stohlawetz P, Brugger S, et al. Elevated numbers of reticulated platelets in hyperthyroidism: direct evidence for an increase of thrombopoiesis. Br J Haematol 1998, 101: 656\u20138.","journal-title":"Br J Haematol"},{"key":"BF03345311_CR6","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1136\/pgmj.66.774.280","volume":"66","author":"HC Ford","year":"1990","unstructured":"Ford HC, Carter JM. Haemostasis in hypothyroidism. Postgrad Med J 1990, 66: 280\u20134.","journal-title":"Postgrad Med J"},{"key":"BF03345311_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2796.1995.tb00899.x","volume":"238","author":"B Myrup","year":"1995","unstructured":"Myrup B, Bregengard C, Faber J. Primary haemostasis in thyroid disease. J Intern Med 1995, 238: 59\u201363.","journal-title":"J Intern Med"},{"key":"BF03345311_CR8","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1177\/107602960100700206","volume":"7","author":"JJ Michiels","year":"2001","unstructured":"Michiels JJ, Schroyens W, Berneman Z, van der Planken M. Acquired von Willebrand syndrome type 1 in hypothyroidism: reversal after treatment with thyroxine. Clin Appl Thromb Hemost 2001, 7: 113\u20135.","journal-title":"Clin Appl Thromb Hemost"},{"key":"BF03345311_CR9","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1210\/jcem.86.2.7221","volume":"86","author":"R Chadarevian","year":"2001","unstructured":"Chadarevian R, Bruckert E, Leenhardt L, Giral P, Ankri A, Turpin G. Components of the fibrinolytic system are differently altered in moderate and severe hypothyroidism. J Clin Endocrinol Metab 2001, 86: 732\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345311_CR10","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1089\/105072502320908312","volume":"12","author":"RC Jenkins","year":"2002","unstructured":"Jenkins RC, Weetman AP. Disease associations with autoimmune thyroid disease. Thyroid 2002, 12: 977\u201388.","journal-title":"Thyroid"},{"key":"BF03345311_CR11","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archinte.1997.00440300155015","volume":"157","author":"LC Hofbauer","year":"1997","unstructured":"Hofbauer LC, Spitzweg C, Schmauss S, Heufelder AE. Graves disease associated with autoimmune thrombocytopenic purpura. Arch Intern Med 1997, 157: 1033\u20136.","journal-title":"Arch Intern Med"},{"key":"BF03345311_CR12","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/ajh.2830390411","volume":"39","author":"N Bizzaro","year":"1992","unstructured":"Bizzaro N. Familial association of autoimmune thrombocytopenia and hyperthyroidism. Am J Hematol 1992, 39: 294\u20138.","journal-title":"Am J Hematol"},{"key":"BF03345311_CR13","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","volume":"346","author":"DB Cines","year":"2002","unstructured":"Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002, 346: 995\u20131008.","journal-title":"N Engl J Med"},{"key":"BF03345311_CR14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1360001","volume":"136","author":"LC Hofbauer","year":"1997","unstructured":"Hofbauer LC, Heufelder AE. Coagulation disorders in thyroid diseases. Eur J Endocrinol 1997, 136: 1\u20137.","journal-title":"Eur J Endocrinol"},{"key":"BF03345311_CR15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/BF03343998","volume":"25","author":"F Marongiu","year":"2002","unstructured":"Marongiu F, Cauli C, Mameli G, Usai B, Mariotti S. Apathetic Graves\u2019 disease and acquired hemophilia due to factor VIIIc antibody. J Endocrinol Invest 2002, 25: 246\u20139.","journal-title":"J Endocrinol Invest"},{"key":"BF03345311_CR16","first-page":"245","volume":"6","author":"R Sievert","year":"1996","unstructured":"Sievert R, Goldstein ML, Surks MI. Graves\u2019 disease and autoimmune factor VIII deficiency. Thyroid 1996, 6: 245\u20137.","journal-title":"Thyroid"},{"key":"BF03345311_CR17","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/BF03350928","volume":"11","author":"F Marongiu","year":"1988","unstructured":"Marongiu F, Conti M, Mameli G, et al. Fibrinogen and fibrinolytic activity in hyperthyroidism before and after antithyroid treatment. J Endocrinol Invest 1988, 11: 723\u20135.","journal-title":"J Endocrinol Invest"},{"key":"BF03345311_CR18","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/BF03344016","volume":"25","author":"C Erem","year":"2002","unstructured":"Erem C, Ersoz H\u00d6, Karti SS, et al. Blood coagulation and fibrinolysis in patients with hyperthyroidism. J Endocrinol Invest 2002, 25: 345\u201350.","journal-title":"J Endocrinol Invest"},{"key":"BF03345311_CR19","doi-asserted-by":"crossref","first-page":"713","DOI":"10.7326\/0003-4819-97-5-713","volume":"97","author":"JS Rogers","year":"1982","unstructured":"Rogers JS, Shane SR, Jencks FS. Factor VIII activity and thyroid function. Ann Intern Med 1982, 97: 713\u20136.","journal-title":"Ann Intern Med"},{"key":"BF03345311_CR20","first-page":"444","volume":"102","author":"JS Rogers","year":"1983","unstructured":"Rogers JS, Shane SR. Factor VIII activity in normal volunteers receiving oral thyroid hormone. J Lab Clin Med 1983, 102: 444\u20139.","journal-title":"J Lab Clin Med"},{"key":"BF03345311_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/BF01469121","volume":"53","author":"E Hiller","year":"1978","unstructured":"Hiller E, Roth W, Wahl R, Kallee E. Thromboplastin activity of extracts of human thyroid glands. Klin Wochenschr 1978, 53: 283\u20134.","journal-title":"Klin Wochenschr"},{"key":"BF03345311_CR22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1055\/s-2007-1003766","volume":"23","author":"F Marongiu","year":"1991","unstructured":"Marongiu F, Conti M, Murtas ML, Mameli G, Sorano GG, Martino E. Activation of blood coagulation and fibrinolysis in Graves\u2019 disease. Horm Metab Res 1991, 23: 609\u201311.","journal-title":"Horm Metab Res"},{"key":"BF03345311_CR23","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1053\/sarh.2002.50011","volume":"32","author":"M Matucci-Cerinic","year":"2003","unstructured":"Matucci-Cerinic M, Valentini G, Sorano GG, et al. Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis. Semin Arthritis Rheum 2003, 32: 285\u201395.","journal-title":"Semin Arthritis Rheum"},{"key":"BF03345311_CR24","doi-asserted-by":"crossref","first-page":"7944","DOI":"10.1016\/S0021-9258(18)34276-5","volume":"257","author":"CT Esmon","year":"1982","unstructured":"Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982, 257: 7944\u20137.","journal-title":"J Biol Chem"},{"key":"BF03345311_CR25","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1055\/s-2002-27815","volume":"28","author":"PG Groot de","year":"2002","unstructured":"de Groot PG. The role of von Willebrand factor in platelet function. Semin Thromb Hemost 2002, 28: 133\u20138.","journal-title":"Semin Thromb Hemost"},{"key":"BF03345311_CR26","first-page":"609","volume":"76","author":"Y Morikawa","year":"1993","unstructured":"Morikawa Y, Morikawa A, Makino I. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves\u2019 disease: TM, a possible new marker of the peripheral activity of thyroid hormones. J Clin Endocrinol Metab 1993, 76: 609\u201314.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345311_CR27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/105072501300042820","volume":"11","author":"J Burggraaf","year":"2001","unstructured":"Burggraaf J, Lalezari S, Emeis JJ, et al. Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol. Thyroid 2001, 11: 153\u201360.","journal-title":"Thyroid"},{"key":"BF03345311_CR28","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/0049-3848(91)90074-7","volume":"64","author":"F Marongiu","year":"1991","unstructured":"Marongiu F, Conti M, Murtas ML, et al. Anticardiolipin antibodies in Graves\u2019 disease: relantionship with thrombin activity in vivo. Thromb Res 1991, 64: 745\u20139.","journal-title":"Thromb Res"},{"key":"BF03345311_CR29","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/j.1365-2265.1994.tb03927.x","volume":"40","author":"A Paggi","year":"1994","unstructured":"Paggi A, Caccavo D, Ferri GM, et al. Anti-cardiolipin antibodies in autoimmune thyroid diseases. Clin Endocrinol 1994, 40: 329\u201333.","journal-title":"Clin Endocrinol"},{"key":"BF03345311_CR30","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1056\/NEJMra002974","volume":"346","author":"JS Levine","year":"2002","unstructured":"Levine JS, Branch DW, Rauch J. The antiphospholipid syndrome. N Engl J Med 2002, 346: 752\u201363.","journal-title":"N Engl J Med"},{"key":"BF03345311_CR31","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1346-8138.2002.tb00222.x","volume":"29","author":"A Takahashi","year":"2002","unstructured":"Takahashi A, Tamura A, Ishikawa O. Antiphospholipid antibody syndrome complicated by Grave\u2019s disease. J Dermatol 2002, 29: 776\u201380.","journal-title":"J Dermatol"},{"key":"BF03345311_CR32","first-page":"1435","volume":"23","author":"LC Hofbauer","year":"1996","unstructured":"Hofbauer LC, Spitzweg C, Heufelder AE. Graves\u2019 disease associated with the primary antiphospholipid syndrome. J Rheumatol 1996, 23: 1435\u20137.","journal-title":"J Rheumatol"},{"key":"BF03345311_CR33","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1055\/s-0038-1649988","volume":"74","author":"JT Brandt","year":"1995","unstructured":"Brandt JT, Barna LK, Triplett DA. Laboratory identification of lupus anticoagulants: results of the Second International Workshop for Identification of Lupus Anticoagulants. On behalf of the Subcommittee on Lupus Anticoagulants\/Antiphospholipid Antibodies of the ISTH. Thromb Haemost 1995, 74: 1597\u2013603.","journal-title":"Thromb Haemost"},{"key":"BF03345311_CR34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1161\/01.STR.26.3.496","volume":"26","author":"CE Siegert","year":"1995","unstructured":"Siegert CE, Smelt AH, de Bruin TW. Superior sagittal sinus thrombosis and thyrotoxicosis. Stroke 1995, 26: 496\u20137.","journal-title":"Stroke"},{"key":"BF03345311_CR35","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1161\/01.STR.27.10.1731","volume":"27","author":"DA Dulli","year":"1996","unstructured":"Dulli DA, Luzzio CC, Williams EC, Schutta HS. Cerebral venous thrombosis and activated protein C resistance. Stroke 1996, 27: 1731\u20133.","journal-title":"Stroke"},{"key":"BF03345311_CR36","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1161\/01.STR.22.3.401","volume":"22","author":"HS Schutta","year":"1991","unstructured":"Schutta HS, Williams EC, Baranski BG, Sutula TP. Cerebral venous thrombosis with plasminogen deficiency. Stroke 1991, 22: 401\u20135.","journal-title":"Stroke"},{"key":"BF03345311_CR37","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1089\/thy.2000.10.607","volume":"10","author":"HJ Verberne","year":"2000","unstructured":"Verberne HJ, Fliers E, Prummel MF, Stam J, Brandjes DP, Wiersinga WM. Thyrotoxicosis as a predisposing factor for cerebral venous thrombosis. Thyroid 2000, 10: 607\u201310.","journal-title":"Thyroid"},{"key":"BF03345311_CR38","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1136\/pgmj.69.816.813","volume":"69","author":"SR Page","year":"1993","unstructured":"Page SR, Scott AR. Thyroid storm in a young woman resulting in bilateral basal ganglia infarction. Postgrad Med J 1993, 69: 813\u20135.","journal-title":"Postgrad Med J"},{"key":"BF03345311_CR39","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200105103441901","volume":"344","author":"I Klein","year":"2001","unstructured":"Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001, 344: 501\u20139.","journal-title":"N Engl J Med"},{"key":"BF03345311_CR40","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/archinte.1988.00380030132023","volume":"148","author":"RA Nordyke","year":"1988","unstructured":"Nordyke RA, Gilbert FI Jr, Harada ASM. Graves\u2019 disease. Influence of age on clinical findings. Arch Intern Med 1988, 148: 626\u201331.","journal-title":"Arch Intern Med"},{"key":"BF03345311_CR41","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1089\/105072502760143863","volume":"12","author":"T Shimizu","year":"2002","unstructured":"Shimizu T, Koide S, Noh JY, Sugino K, Ito K, Nakazawa H. Hyperthyroidism and the management of atrial fibrillation. Thyroid 2002, 12: 489\u201393.","journal-title":"Thyroid"},{"key":"BF03345311_CR42","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1056\/NEJM199411103311901","volume":"331","author":"CT Sawin","year":"1994","unstructured":"Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994, 331: 1249\u201352.","journal-title":"N Engl J Med"},{"key":"BF03345311_CR43","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/105072502760143881","volume":"12","author":"CT Sawin","year":"2002","unstructured":"Sawin CT. Subclinical hyperthyroidism and atrial fibrillation. Thyroid 2002, 12: 501\u20133.","journal-title":"Thyroid"},{"key":"BF03345311_CR44","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","volume":"358","author":"JV Parle","year":"2001","unstructured":"Parle JV, Maisonneuve P, Sheppard MC, Boyle P, Franklyn JA. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 2001, 358: 861\u20135.","journal-title":"Lancet"},{"key":"BF03345311_CR45","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1067\/mhj.2001.119370","volume":"142","author":"J Auer","year":"2001","unstructured":"Auer J, Scheibner P, Mische T, Langsteger W, Eber O, Eber B. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. Am Heart J 2001, 142: 838\u201342.","journal-title":"Am Heart J"},{"key":"BF03345311_CR46","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0002-9149(79)90243-1","volume":"44","author":"JC Forfar","year":"1979","unstructured":"Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a correctable cause of \u201cidiopathic\u201d atrial fibrillation. Am J Cardiol 1979, 44: 9\u201312.","journal-title":"Am J Cardiol"},{"key":"BF03345311_CR47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jcem.87.3.8217","volume":"87","author":"F Osman","year":"2002","unstructured":"Osman F, Gammage MD, Sheppard MC, Franklyn JA. Clinical review 142: cardiac dysrhythmias and thyroid dysfunction: the hidden menace? J Clin Endocrinol Metab 2002, 87: 963\u20137.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03345311_CR48","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1136\/bmj.2.6088.688","volume":"2","author":"JS Staffurth","year":"1977","unstructured":"Staffurth JS, Gibberd MC, Fui SN. Arterial embolism in thyrotoxicosis with atrial fibrillation. Br Med J 1977, 2: 688\u201390.","journal-title":"Br Med J"},{"key":"BF03345311_CR49","doi-asserted-by":"crossref","first-page":"630","DOI":"10.5694\/j.1326-5377.1979.tb119428.x","volume":"1","author":"RW Yuen","year":"1979","unstructured":"Yuen RW, Gutteridge DH, Thompson PL, Robinson JS. Embolism in thyrotoxic atrial fibrillation. Med J Aust 1979, 1: 630\u20131.","journal-title":"Med J Aust"},{"key":"BF03345311_CR50","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1445-5994.1981.tb03519.x","volume":"11","author":"DM Hurley","year":"1981","unstructured":"Hurley DM, Hunter AN, Hewett MJ, Stockigt JR. Atrial fibrillation and arterial embolism in hyperthyroidism. Aust N Z J Med 1981, 11: 391\u20133.","journal-title":"Aust N Z J Med"},{"key":"BF03345311_CR51","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1001\/archinte.1981.00340090087019","volume":"141","author":"S Bar-Sela","year":"1981","unstructured":"Bar-Sela S, Ehrenfeld M, Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med 1981, 141: 1191\u20132.","journal-title":"Arch Intern Med"},{"key":"BF03345311_CR52","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/01.STR.19.1.15","volume":"19","author":"P Petersen","year":"1988","unstructured":"Petersen P, Hansen JM. Stroke in thyrotoxicosis with atrial fibrillation. Stroke 1988, 19: 15\u20138.","journal-title":"Stroke"},{"key":"BF03345311_CR53","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1136\/bmj.312.7022.45","volume":"312","author":"GYH Lip","year":"1996","unstructured":"Lip GYH, Lowe GDO. ABC of atrial fibrillation: antithrombotic treatment for atrial fibrillation. BMJ 1996, 312: 45\u20139.","journal-title":"BMJ"},{"key":"BF03345311_CR54","unstructured":"A guide to oral anticoagulant treatment. Recommendations of the Italian Federation of Anticoagulation Clinics (FCSA). Haematologica 2003, 88 (Suppl 2): 1\u201352."},{"key":"BF03345311_CR55","doi-asserted-by":"crossref","first-page":"194S","DOI":"10.1378\/chest.119.1_suppl.194S","volume":"119","author":"GW Albers","year":"2001","unstructured":"Albers GW, Dalen JE, Laupacis A, Manning WJ, Petersen P, Singer DE. Antithrombotic therapy in atrial fibrillation. Chest 2001, 119: 194S\u2013206S.","journal-title":"Chest"},{"key":"BF03345311_CR56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0002-9343(82)90850-6","volume":"72","author":"HK Nakazawa","year":"1982","unstructured":"Nakazawa HK, Sakurai K, Hamada N, Nomotani N, Ito K. Management of atrial fibrillation in the post-thyrotoxic state. Am J Med 1982, 72: 903\u20136.","journal-title":"Am J Med"},{"issue":"Suppl","key":"BF03345311_CR57","doi-asserted-by":"crossref","first-page":"46G","DOI":"10.1016\/S0002-9149(00)00993-0","volume":"86","author":"O Kamp","year":"2000","unstructured":"Kamp O, Verhorst PMJ, Visser CA. Transesophageal echocardiography for early cardioversion of atrial fibrillation. Am J Cardiol 2000, 86 (Suppl): 46G\u201350G.","journal-title":"Am J Cardiol"},{"key":"BF03345311_CR58","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0140-6736(96)01109-9","volume":"348","author":"G Palareti","year":"1996","unstructured":"Palareti G, Leali N, Cocchieri S, et al. Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Lancet 1996, 348: 423\u20138.","journal-title":"Lancet"},{"key":"BF03345311_CR59","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/archinte.160.4.470","volume":"160","author":"G Palareti","year":"2000","unstructured":"Palareti G, Hirsh J, Legnani C, et al. Oral anticoagulation treatment in the elderly: a nested, prospective, case-control study. Arch Intern Med 2000, 160: 470\u20138.","journal-title":"Arch Intern Med"},{"key":"BF03345311_CR60","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1055\/s-0037-1615385","volume":"80","author":"D Barcellona","year":"1998","unstructured":"Barcellona D, Vannini ML, Fenu L, Balestrieri C, Marongiu F. Warfarin or acenocoumarol: which is better in the management of oral anticoagulants? Thromb Haemost 1998, 80: 899\u2013902.","journal-title":"Thromb Haemost"},{"key":"BF03345311_CR61","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/0140-6736(92)91739-U","volume":"340","author":"F Marongiu","year":"1992","unstructured":"Marongiu F, Sorano GG, Conti M, et al. Known vitamin K intake and management of poorly controlled oral anticoagulant therapy. Lancet 1992, 340: 545\u20136.","journal-title":"Lancet"},{"key":"BF03345311_CR62","doi-asserted-by":"crossref","first-page":"676","DOI":"10.7326\/0003-4819-121-9-199411010-00009","volume":"121","author":"PS Wells","year":"1994","unstructured":"Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med 1994, 121: 676\u201383.","journal-title":"Ann Intern Med"},{"key":"BF03345311_CR63","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1055\/s-0038-1642530","volume":"71","author":"C Manotti","year":"1994","unstructured":"Manotti C, Quintavalla R, Pattaccini C, Pini M. Seasonal variation of oral anticoagulant effect. Thromb Haemost 1994, 71: 802\u20133.","journal-title":"Thromb Haemost"},{"key":"BF03345311_CR64","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1055\/s-0038-1651604","volume":"69","author":"S Cortellazzo","year":"1993","unstructured":"Cortellazzo S, Finazzi G, Viero P, et al. Thrombotic and hemorrhagic complications in patients with mechanical heart valve prosthesis attending an anticoagulation clinic. Thromb Haemost 1993, 69: 316\u201320.","journal-title":"Thromb Haemost"},{"key":"BF03345311_CR65","first-page":"1081","volume":"87","author":"D Barcellona","year":"2002","unstructured":"Barcellona D, Contu P, Marongiu F. Patient education and oral anticoagulant therapy. Haematologica 2002, 87: 1081\u20136.","journal-title":"Haematologica"},{"key":"BF03345311_CR66","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1055\/s-0037-1613756","volume":"83","author":"D Barcellona","year":"2000","unstructured":"Barcellona D, Contu P, Sorano GG, Pengo V, Marongiu F. The management of oral anticoagulant therapy: the patient\u2019s point of view. Thromb Haemost 2000, 83: 49\u201353.","journal-title":"Thromb Haemost"},{"key":"BF03345311_CR67","first-page":"43","volume":"58","author":"HA Kellett","year":"1986","unstructured":"Kellett HA, Sawers JS, Boulton FE, Cholerton S, Park BK, Toft AD. Problems of anticoagulation with warfarin in hyperthyroidism. Q J Med 1986, 58: 43\u201351.","journal-title":"Q J Med"},{"key":"BF03345311_CR68","first-page":"387","volume":"33","author":"TH Self","year":"1976","unstructured":"Self TH, Straughn AB, Weisburst MR. Effect of hyperthyroidism on hypoprothrombinemic response to warfarin. Am J Hosp Pharm 1976, 33: 387\u20139.","journal-title":"Am J Hosp Pharm"},{"key":"BF03345311_CR69","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1055\/s-0038-1648535","volume":"67","author":"F Marongiu","year":"1992","unstructured":"Marongiu F, Biondi G, Conti M, et al. Is a hypercoagulable state present in hypothyroidism? Thromb Haemost 1992, 67: 729.","journal-title":"Thromb Haemost"},{"key":"BF03345311_CR70","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1046\/j.1365-2362.2001.00777.x","volume":"31","author":"B Muller","year":"2001","unstructured":"Muller B, Tsakiris DA, Roth CB, Guglielmetti M, Staub JJ, Marbet GA. Haemostatic profile in hypothyroidism as potential risk factor for vascular or thrombotic disease. Eur J Clin Invest 2001, 31: 131\u20137.","journal-title":"Eur J Clin Invest"},{"key":"BF03345311_CR71","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1089\/thy.1999.9.1163","volume":"9","author":"B Catargi","year":"1999","unstructured":"Catargi B, Parrot-Roulaud F, Cochet C, Ducassou D, Roger P, Tabarin A. Homocysteine, hypothyroidism, and effect of thyroid hormone replacement. Thyroid 1999, 9: 1163\u20136.","journal-title":"Thyroid"},{"key":"BF03345311_CR72","doi-asserted-by":"crossref","first-page":"348","DOI":"10.7326\/0003-4819-131-5-199909070-00005","volume":"131","author":"WI Hussein","year":"1999","unstructured":"Hussein WI, Green R, Jacobsen DW, Faiman C. Normalization of hyperhomocysteinemia with L-thyroxine in hypothyroidism. Ann Intern Med 1999, 131: 348\u201351.","journal-title":"Ann Intern Med"},{"key":"BF03345311_CR73","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S0026-0495(98)90198-6","volume":"47","author":"BG Nedrebo","year":"1998","unstructured":"Nedrebo BG, Ericsson UB, Nygard O, et al. Plasma total homocysteine levels in hyperthyroid and hypothyroid patients. Metabolism 1998, 47: 89\u201393.","journal-title":"Metabolism"},{"key":"BF03345311_CR74","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/S0735-1097(02)02069-7","volume":"40","author":"A Tawakol","year":"2002","unstructured":"Tawakol A, Forgione MA, Stuehlinger M, et al. Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol 2002, 40: 1051\u20138.","journal-title":"J Am Coll Cardiol"},{"key":"BF03345311_CR75","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/edrv-6-3-432","volume":"6","author":"C Becker","year":"1985","unstructured":"Becker C. Hypothyroidism and atherosclerotic heart disease: pathogenesis, medical management, and the role of coronary artery bypass surgery. Endocr Rev 1985, 6: 432\u201340.","journal-title":"Endocr Rev"},{"key":"BF03345311_CR76","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/10507250050137743","volume":"10","author":"GJ Kahaly","year":"2000","unstructured":"Kahaly GJ. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 2000, 10: 665\u201379.","journal-title":"Thyroid"}],"container-title":["Journal of Endocrinological Investigation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345311.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03345311\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03345311","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T06:12:01Z","timestamp":1746166321000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03345311"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":76,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["BF03345311"],"URL":"https:\/\/doi.org\/10.1007\/bf03345311","relation":{},"ISSN":["0391-4097","1720-8386"],"issn-type":[{"value":"0391-4097","type":"print"},{"value":"1720-8386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}